SPY417.26+1.39 0.33%
DIA341.86+1.53 0.45%
IXIC14,052.34+13.58 0.10%

Oil falls amid stockpiling concern; European vaccine woe threatens demand

· 03/15/2021 22:13
Oil falls amid stockpiling concern; European vaccine woe threatens demand

- Oil prices fell on Tuesday, extending declines for a third day, as concerns about rising stockpiles in the United States added to the threat to demand posed by countries including Germany and France halting COVID-19 vaccinations.

Brent crude LCOc1 was down 58 cents, or 0.8%, at $68.30 by 0041 GMT, having dropped 0.5% on Monday. U.S. crude CLc1 was down 61 cents, or 0.9%, at $64.78 a barrel, after declining 0.3% in the previous session.

Germany, France and Italy plan to suspend AstraZeneca PLC AZN.L COVID-19 injections after reports of possible serious side effects, although the World Health Organization said there was no established link to the vaccine.

These moves are deepening concerns over a slow pace of vaccinations in the region, which may delay any economic recovery from the pandemic in one of the hardest-hit areas. nL1N2LD0O2

The pandemic eviscerated demand for oil but prices have recovered to levels before the global health crisis, only to be capped as vaccination rollouts have been slow in most countries.

In the United States, stockpiles are also rising because of last month's "big freeze" which halted refining operations that have taken time to fully return.

"Crude oil inventories have increased substantially in recent weeks, as a result of U.S. refinery disruptions, which have seen crude oil stocks approaching 500 million barrels," ING Economics said in a client note.

The American Petroleum Institute, an industry group, will report crude stock pile levels later on Tuesday, followed by official numbers from the Department of Energy on Wednesday, with analysts expecting another week of gain. API/S

Crude inventories increased by 12.8 million barrels in the week to March 5, against analysts' expectations for a rise of less than 1 million barrels.


(Reporting by Aaron Sheldrick; Editing by Christopher Cushing)

((aaron.sheldrick@thomsonreuters.com; 81-80-2677-4134;))